RUMORED BUZZ ON ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS

“The current scenario has uncovered some structural weaknesses in the EU’s medicines offer chain plus a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She recommended that supply chain issues be addressed in an EU pharmaceutical tactic anticipated for being introduced by the top from the year.T